Perpetua Resources Corp. (Nasdaq: PPTA) (TSX: PPTA) (“Perpetua Resources” or “Perpetua” or the “Company”) announced today that its unaudited condensed consolidated financial results for the period ended June 30, 2025 were filed. For details, please see the Company's filings available on EDGAR and SEDAR. Perpetua Resources' vision is to provide the U.S. with a domestic […]
VivoSim Labs Appoints Tony Lialin as Chief Commercial Officer Veteran commercial leader to scale AI-enabled NAMkind(TM) liver and intestine toxicology services in a rapidly growing market GlobeNewswire August 14, 2025 SAN DIEGO, Aug. 14, 2025 (GLOBE NEWSWIRE) — VivoSim Labs, Inc. (Nasdaq: VIVS) (the “Company” or “VivoSim Labs”), a pharmaceutical and biotechnology services company that
24/7 Market News: LIXTE Biotech Advances Precision Oncology Pipeline with Multiple Phase 1B/2 Trial Readouts Expected in 2H 2025 Breakthrough Epigenetic Modulator LB-100 Targets Ovarian Clear Cell Carcinoma, Advanced Soft Tissue Sarcoma, and MSS Metastatic Colon Cancer GlobeNewswire August 14, 2025 DENVER, Aug. 14, 2025 (GLOBE NEWSWIRE) — 247marketnews.com, a pioneer in digital media dedicated
Candel Therapeutics Reports Second Quarter 2025 Financial Results and Recent Corporate Highlights GlobeNewswire August 14, 2025 Presented positive results from the phase 3 randomized, placebo-controlled clinical trial of CAN-2409 (aglatimagene besadenovec) in localized prostate cancer, during an oral presentation at the 2025 Annual Meeting of the American Society of Clinical Oncology (ASCO) Received FDA Regenerative
Outlook Therapeutics Reports Financial Results for Third Quarter Fiscal Year 2025 and Provides Corporate Update GlobeNewswire August 14, 2025 First commercial sales of LYTENAVA(TM) (bevacizumab gamma) achieved in Europe ONS-5010/LYTENAVA(TM) (bevacizumab-vikg) Prescription Drug User Fee Act (PDUFA) goal date of August 27, 2025, in the United States ISELIN, N.J., Aug. 14, 2025 (GLOBE NEWSWIRE) —
Collaboration focused on undisclosed GPCR targets Company to receive an upfront and near-term payments, including an equity investment, as well as additional development and commercial milestones, and tiered royalties Superluminal Medicines, a drug discovery company integrating AI/ML, protein dynamics, and structural biology to rapidly unlock the most challenging G protein-coupled receptors (GPCRs), today announced a
Madison Street Capital and its broker-dealerMSC-BD (MSC), an international investment banking firm, acted as the exclusive advisor in the sale of American Anchor Bolt to Salt Creek Capital, a private equity firm based in Woodside, CA. Founded in 1996 by Myrna Tucker and headquartered in Houston, TX, American Anchor Bolt produces customized anchor bolts and
Crypto Funds Watch, a monthly publication with a curated community of more than 4,000 institutional professionals in the crypto funds sector, has announced the successful acquisition of CryptoFund.News, a niche news outlet exclusively covering crypto hedge funds, crypto quants, and digital asset managers. Founded in 2020, the team behind CryptoFund.News has deep roots in the
Protective DNS helps companies stay safe from fileless malware DNSFilter released new research today that showcases how bad actors are taking advantage of fake CAPTCHA pages to attempt to scam unsuspecting individuals. One ofDNSFilter's managed service provider (MSP) customers discovered what first appeared to be an ordinary CAPTCHA prompt, but it turned out to be
40-yearlegacyclinicacceleratesnextchapterofinnovationandexcellenceinLosAngeles Pinnacle Fertility California, formerly known as California Fertility Partners, proudly announces the addition of nationally renowned reproductive endocrinologist Dr. Kristin Bendikson to its world-class physician team. Dr. Bendikson will begin seeing patients October 6, deepening the clinic's reach as a global destination for advanced fertility care. https://mma.prnewswire.com/media/1757555/Pinnacle_Fertility_Logo_1.jpg “Joining Pinnacle Fertility California means becoming part